Advancing Therapies for Neurological Disorders and Rare Diseases
At Acadia, our mission is to turn scientific promise into meaningful innovation that makes the difference for underserved neurological disorders and rare disease communities around the world. Currently, our clinical-stage developments focus on addressing Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with early-stage programs that address other unmet patient needs.
Leading the Way in Rett Syndrome Therapy
Our commitment is unwavering towards creating a brighter future for individuals living with rare diseases and their families. Our efforts continue to focus on broadening access to essential therapies for families across the globe.
